Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Pinus Taeda Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of seasonal allergies caused by the Loblolly Pine. It belongs to the class of non-standardized pollen allergenic extracts.
Name
Pinus Taeda Pollen
Raw Name
PINUS TAEDA POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
11
Variant Count
12
Last Verified
February 17, 2026
About Pinus Taeda Pollen
Pinus Taeda Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of seasonal allergies caused by the Loblolly Pine. It belongs to the class of non-standardized pollen allergenic extracts.
Detailed information about Pinus Taeda Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Pinus Taeda Pollen.
Pinus Taeda Pollen, derived from the Pinus taeda tree (commonly known as the Loblolly Pine), is a biological substance used primarily in the field of allergy and immunology. It belongs to a pharmacological class known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are complex mixtures of proteins, glycoproteins, and polysaccharides harvested from the male cones of the Loblolly Pine during its peak pollination season. In the United States, the Loblolly Pine is a dominant species across the Southeast, making its pollen a significant contributor to seasonal allergic rhinitis (hay fever) and allergic conjunctivitis (eye allergies).
As a non-standardized extract, Pinus Taeda Pollen is labeled based on its weight-to-volume (w/v) ratio or its Protein Nitrogen Unit (PNU) content, rather than a specific biological potency measure. This distinguishes it from 'standardized' extracts (like certain grasses or dust mites) which have federally mandated potency tests. The FDA has permitted the use of these extracts for decades, acknowledging their clinical utility in both identifying specific allergens through skin testing and desensitizing patients through allergen immunotherapy (AIT).
The mechanism of Pinus Taeda Pollen depends on its application: diagnostic or therapeutic. When used for diagnostic skin testing, the extract is introduced into the epidermis (the top layer of skin). If a patient is sensitized, pre-existing Immunoglobulin E (IgE) antibodies bound to mast cells recognize the pine pollen proteins. This recognition triggers 'degranulation,' where mast cells release inflammatory mediators like histamine and leukotrienes. This results in a 'wheal and flare' reaction—a raised, itchy bump surrounded by redness—confirming the patient's sensitivity to Pinus taeda.
In a therapeutic context (immunotherapy), the extract works by gradually re-training the immune system. Repeated, escalating doses of the pollen extract shift the immune response from a Th2-dominated profile (which promotes IgE and allergic inflammation) to a Th1-dominated profile. This process induces the production of 'blocking antibodies,' specifically Immunoglobulin G4 (IgG4), which compete with IgE for allergen binding. Furthermore, immunotherapy promotes the activity of regulatory T-cells (Tregs), which secrete anti-inflammatory cytokines like Interleukin-10 (IL-10), effectively dampening the allergic cascade over a period of three to five years.
Because allergenic extracts are biological proteins administered via subcutaneous (under the skin) or epicutaneous (on the skin) routes, they do not follow traditional small-molecule pharmacokinetics.
Pinus Taeda Pollen extracts are FDA-approved for the following indications:
Pinus Taeda Pollen is available in several concentrated liquid forms, typically supplied in multi-dose vials:
> Important: Only your healthcare provider can determine if Pinus Taeda Pollen is right for your specific condition. Immunotherapy should only be conducted under the supervision of a board-certified allergist/immunologist.
Dosage for Pinus Taeda Pollen is highly individualized and is never a 'one-size-fits-all' regimen. Healthcare providers determine the dose based on the patient's level of sensitivity (determined by skin test results) and their tolerance during the build-up phase.
Pinus Taeda Pollen extracts are used in children, but extreme caution is required. Dosing is generally calculated using the same principles as adult dosing—starting with very low concentrations and increasing based on tolerance. Most allergists do not recommend starting immunotherapy in children under the age of 5 due to the difficulty of communicating systemic symptoms. Pediatric patients must be monitored even more closely for signs of anaphylaxis.
No specific dose adjustments are required for patients with kidney disease, as the proteins are metabolized by local proteases. However, the patient's overall health must be stable to handle potential systemic reactions.
No dose adjustments are necessary for patients with liver disease.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. If an elderly patient experiences a systemic reaction, their heart may not tolerate the stress of the reaction or the high doses of epinephrine required to treat it.
Pinus Taeda Pollen extracts are for professional use only and are never self-administered by the patient at home.
If a dose is missed during the build-up phase, the allergist may need to repeat the previous dose or even reduce the dose, depending on how much time has elapsed. During the maintenance phase, a delay of more than 1-2 weeks may require a temporary dose reduction to ensure safety. Never attempt to 'double up' on doses to catch up.
An 'overdose' in the context of allergenic extracts usually refers to an injection given at a concentration higher than the patient's current tolerance level.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Always inform your nurse if you are feeling unwell or have had a recent asthma flare-up before receiving your injection.
Most patients undergoing immunotherapy with Pinus Taeda Pollen will experience local reactions. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Pinus Taeda Pollen and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' effects of Pinus Taeda Pollen extracts on organs like the liver or kidneys. The primary long-term risk is the development of new sensitivities, though immunotherapy is generally thought to prevent the 'allergic march' (the development of new allergies and asthma).
While individual non-standardized extracts may not always carry a specific boxed warning on every vial, the entire class of allergenic extracts is subject to the following safety consensus:
Report any unusual symptoms, especially those occurring several hours after an injection (late-phase reactions), to your healthcare provider immediately.
Pinus Taeda Pollen extract is a potent biological product. Safety depends entirely on correct administration and patient compliance. Patients must be 'clinically stable' before receiving an injection. This means no active asthma symptoms and no current febrile illness (fever).
No specific FDA black box warning exists for the individual Pinus Taeda Pollen extract; however, the FDA-approved labeling for all subcutaneous allergenic extracts emphasizes that they can cause severe anaphylactic shock. Death has occurred in rare instances. Patients with high degrees of sensitivity or those with unstable asthma are at the highest risk.
Most patients can drive after their 30-minute observation period. However, if a patient experiences significant fatigue or a mild systemic reaction, they should avoid driving until symptoms have completely resolved.
Alcohol should be avoided on the day of an injection. Alcohol causes vasodilation (widening of blood vessels), which can theoretically increase the speed of allergen absorption and increase the risk or severity of a systemic reaction.
Immunotherapy is typically discontinued if:
> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Pinus Taeda Pollen.
There are no direct food-drug interactions with Pinus Taeda Pollen. However, patients with 'Oral Allergy Syndrome' (Pollen-Food Allergy Syndrome) may find that their sensitivity to certain raw fruits or vegetables increases during the peak pine pollen season or during the build-up phase of immunotherapy.
For each major interaction, the mechanism is usually pharmacodynamic (affecting how the body responds to the allergen or the rescue medication). Management involves careful screening of the patient's medication list before every single injection.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including eye drops and over-the-counter allergy pills.
Patients allergic to Pinus taeda often show cross-reactivity with other members of the Pinaceae family, including:
This means that a patient sensitized to Loblolly Pine will likely test positive for these other species, and a 'Pine Mix' extract is often used in clinical practice to cover multiple species simultaneously.
> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and heart health, before prescribing Pinus Taeda Pollen.
Pinus Taeda Pollen is classified as FDA Pregnancy Category C. This means there are no adequate, well-controlled studies in pregnant women.
It is generally considered safe to continue Pinus Taeda Pollen immunotherapy while breastfeeding. The large protein molecules in the extract are not expected to pass into breast milk in any significant or harmful quantity. There is no evidence that this affects the nursing infant's immune system.
As noted, Pinus Taeda Pollen is used in the pediatric population, typically for children aged 5 and older. The primary concern in younger children is their inability to describe the early, 'aura-like' symptoms of a systemic reaction (such as an itchy throat or a sense of 'impending doom'). Studies have shown that immunotherapy in children can prevent the development of asthma later in life.
Patients over age 65 require a thorough cardiovascular workup before beginning therapy. The elderly are more likely to be on medications like beta-blockers or ACE inhibitors, and their physiological reserve to survive a severe anaphylactic event is reduced. Dosing should be approached with extreme caution.
No specific studies have been conducted in patients with renal impairment. However, since the clearance of these proteins is not primarily renal-dependent, no dose adjustments are standard. The patient's overall fluid status and stability should be monitored.
No dose adjustments are required for patients with liver disease. The metabolic pathway of allergenic proteins does not involve the liver's cytochrome P450 system.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you become pregnant or develop a new medical condition during treatment.
Pinus Taeda Pollen extract acts as an immunomodulator. The Loblolly Pine pollen contains several major allergens, including proteins that are recognized by the immune system's B-cells and T-cells.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Epicutaneous only) |
| Protein Binding | Primarily bound by specific IgE and IgG4 antibodies |
| Half-life | Varies (Proteins are degraded within hours/days) |
| Tmax | 15-30 minutes for local mast cell activation |
| Metabolism | Local and systemic proteolysis (protein breakdown) |
| Excretion | Renal (as peptide fragments) |
Pinus Taeda Pollen extract is a complex biological mixture. It is not a single chemical formula. It contains:
Pinus Taeda Pollen is classified as a Non-Standardized Pollen Allergenic Extract. It is related to other tree pollen extracts like Oak, Hickory, and Pecan, which are also used for diagnostic and therapeutic purposes in allergic disease management.
Common questions about Pinus Taeda Pollen
Pinus Taeda Pollen extract is primarily used for the diagnosis and treatment of seasonal allergies caused by the Loblolly Pine tree. In diagnostic settings, it is used in skin prick tests to identify if a patient's respiratory symptoms, such as sneezing or itchy eyes, are caused by this specific pine species. In therapeutic settings, it is used in allergen immunotherapy, commonly known as allergy shots. This process involves giving gradually increasing doses of the pollen extract to desensitize the patient's immune system over several years. It is specifically indicated for patients with allergic rhinitis, conjunctivitis, or allergic asthma who do not get enough relief from standard medications.
The most common side effects are local reactions at the site of the injection or skin test. These include redness, swelling, itching, and a small raised bump known as a wheal. These reactions usually appear within minutes and typically resolve within 24 to 48 hours. Some patients may also experience a 'late-phase' reaction, where the swelling returns several hours later. Systemic side effects, though less common, can include tiredness, mild headache, or a temporary flare-up of hay fever symptoms. Because of the risk of more serious reactions like anaphylaxis, all injections must be given in a doctor's office with a mandatory 30-minute observation period.
Healthcare providers generally recommend avoiding alcohol on the days you receive a Pinus Taeda Pollen injection. Alcohol acts as a vasodilator, meaning it widens your blood vessels, which can potentially speed up the absorption of the allergen into your bloodstream. This increased absorption rate may raise the risk of a systemic allergic reaction or make a reaction more severe if it occurs. Furthermore, alcohol can mask the early symptoms of an allergic reaction, such as dizziness or flushing, making it harder for you or your doctor to recognize an emergency. It is best to wait at least 24 hours after your injection before consuming alcohol.
Pinus Taeda Pollen is classified as Pregnancy Category C, and its safety during pregnancy has not been fully established. Most allergists will not start a new course of immunotherapy during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could be dangerous for both the mother and the developing baby. However, if a woman is already on a stable maintenance dose and is tolerating the injections well, the doctor may decide to continue the treatment throughout the pregnancy. The decision is highly individualized and depends on the severity of the mother's allergies and her history of reactions to the shots. Always inform your allergist immediately if you become pregnant.
Immunotherapy with Pinus Taeda Pollen is a long-term commitment and does not provide immediate relief like an antihistamine or nasal spray. Most patients begin to notice a reduction in their allergy symptoms during the first pine pollen season after they reach their maintenance dose, which usually takes 3 to 6 months of weekly injections. Significant improvement is typically seen after 12 months of consistent treatment. For the best and most long-lasting results, the treatment is usually continued for a total of 3 to 5 years. If there is no noticeable improvement after two years of maintenance therapy, your doctor may re-evaluate the treatment plan.
Yes, you can stop taking Pinus Taeda Pollen injections suddenly without experiencing any physical withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year course is finished may result in the return of your allergy symptoms. If you stop during the build-up phase, you will not have achieved the necessary immune changes to provide long-term relief. If you need to stop due to a move or a change in health, discuss it with your allergist first. They may be able to help you find a new provider or adjust your schedule to keep the treatment effective.
If you miss a scheduled injection of Pinus Taeda Pollen, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to take an extra dose later to make up for the missed one. If only a few days have passed, your doctor may give you your regular dose. However, if several weeks have passed, your immune system's sensitivity may have increased, and your doctor will likely need to reduce your dose for safety before gradually building it back up again. Consistency is key to the success of immunotherapy, so try to stick to your schedule as closely as possible.
There is no scientific evidence to suggest that Pinus Taeda Pollen allergenic extracts cause weight gain. Unlike systemic corticosteroids (like prednisone), which are sometimes used to treat severe allergies and are known to cause weight changes, allergenic extracts are biological proteins that work specifically on the immune system's response to pollen. They do not affect your metabolism, appetite, or fat storage. If you notice weight gain while undergoing immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking, and you should discuss it with your primary care physician.
Pinus Taeda Pollen can be taken alongside most common allergy medications, such as antihistamines, nasal steroids, and asthma inhalers. In fact, these medications are often used together to manage symptoms while the immunotherapy is taking effect. However, it is critical to tell your doctor if you are taking beta-blockers, MAO inhibitors, or tricyclic antidepressants, as these can make the treatment more dangerous or make it harder to treat a reaction. You should also inform your doctor about any new medications you start during your course of immunotherapy, as some drugs can affect your heart's ability to handle a systemic reaction.
The concept of 'generic' vs. 'brand name' works differently for allergenic extracts like Pinus Taeda Pollen than it does for pills. These extracts are biological products manufactured by several different specialized laboratories (such as ALK, Greer, or HollisterStier). While the extracts from different companies are all Loblolly Pine pollen, they are not considered exactly identical or 'interchangeable' because they are non-standardized. If your allergist switches the brand of extract they use, they will usually perform a 'test dose' or reduce your dose slightly to ensure you can tolerate the new company's formulation safely.